Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis

Haque Waqar; Dabaja Bouthaina; Tann Anne; Khan Mohammad; Szeja Sean; Butler E. Brian; Teh Bin S.

首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis

【24h】

Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis

机译：利妥昔单抗后早期弥漫性大B细胞淋巴瘤的治疗方式变化和放疗影响：基于人群的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Use of Rituximab for diffuse large B cell lymphoma (DLBCL) has improved outcomes and led to further questions regarding the benefit of consolidative radiation therapy (RT). This study sought to determine changes in RT utilization following the incorporation of Rituximab for treatment of early stage DLBCL and to examine survival outcomes.

机译：目的：利妥昔单抗用于弥漫性大B细胞淋巴瘤（DLBCL）的使用已改善了结局，并导致了关于巩固放射疗法（RT）的益处的进一步疑问。这项研究试图确定合并利妥昔单抗治疗早期DLBCL后RT利用率的变化，并检查生存结果。

著录项

来源
《Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology》 |2016年第1期|共6页
作者
Haque Waqar; Dabaja Bouthaina; Tann Anne; Khan Mohammad; Szeja Sean; Butler E. Brian; Teh Bin S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Diffuse large B cell lymphoma; Radiation therapy utilization; Rituximab;

机译：弥漫性大B细胞淋巴瘤;放射治疗的应用;利妥昔单抗;

相似文献

外文文献
中文文献
专利

1. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis [J] . Haque Waqar, Dabaja Bouthaina, Tann Anne, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2016,第1期

机译：利妥昔单抗后早期弥漫性大B细胞淋巴瘤的治疗方式变化和放疗影响：基于人群的分析
2. The Role of Consolidative Radiotherapy after a Complete Response to Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results from a Systematic Review with a Meta-Analysis [J] . Hu Chunhong, Deng Chao, Zou Wen, Acta Haematologica . 2015,第2期

机译：化疗完全缓解后合并放疗在利妥昔单抗时代弥漫性大B细胞淋巴瘤治疗中的作用：系统评价和荟萃分析的结果
3. Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: A population-based cohort study on treatment, toxicity and outcome [J] . BoslooperK., KibbelaarR., StormH., Leukemia and lymphoma . 2014,第3期

机译：利妥昔单抗，环磷酰胺，阿霉素，长春新碱和泼尼松龙治疗对老年弥漫性大B细胞淋巴瘤患者是有益的但有毒性：基于人群的治疗，毒性和预后队列研究
4. Pathological Analysis of Diffuse Large B-Cell Lymphoma and Clinical Treatment with Chinese and Western Medicine [C] . Xianhui Liu, Xiaona Guo, Chunsheng Yan International Conference on Management, Education, Information and Control . 2016

机译：弥漫性大B细胞淋巴瘤的病理分析及中西医临床治疗
5. Prognostic Biomarkers for Diffuse Large B Cell Lymphoma Patient Survival after Treatment with Chemotherapy: A Retrospective Analysis of 88 Cases [D] . Bushra, Hamama tul. 2019

机译：弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物：88例回顾性分析
6. Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis [O] . Sara Khor, Jaclyn Beca, Murray Krahn, 2014

机译：利妥昔单抗治疗弥漫性大B细胞淋巴瘤患者的现实成本和成本效益：基于人群的分析
7. Changes in Treatment Patterns and Overall Survival for Early-Stage Diffuse Large B Cell Lymphoma in the United States After Rituximab: A Population-Based Analysis [O] . W. Haque, A.W.J. Tann, S. Szeja, 2016

机译：治疗模式的变化和早期弥漫性大B细胞淋巴瘤在RITuximab后的改变和整体存活：基于人群的分析

Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis

摘要

著录项

相似文献

相关主题

期刊订阅